Ben is a senior editor for BioPharma Dive. He is a veteran business journalist with 15 years of experience covering a variety of sectors. Prior to joining Industry Dive, Ben spent six-plus years with Xconomy writing about biotech, specializing in unique angles, profiles, features, enterprise pieces and more. A lifelong New Yorker, Brooklyn transplant and Yankees/Giants/Knicks fan, Ben is trying to cope with a recent move to the suburbs of Virginia, where he spends most of his time chasing after his rambunctious toddler. Ben has a B.A. from Binghamton University.
211 articles by Ben Fidler
-
5 takeaways from AACR, one of the year's top meetings on cancer drugs
April 12, 2021 -
Sanofi buys an mRNA startup in another bet on 'off-the-shelf' cell therapy
April 9, 2021 -
Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine
April 9, 2021 -
With new data, Merck could be first to bring immunotherapy to early kidney cancer
April 8, 2021 -
AstraZeneca's coronavirus vaccine possibly linked to rare blood clots, EMA says
April 7, 2021 -
FibroGen admits misleading safety data for anemia drug, dimming prospects
April 7, 2021 -
Ionis cuts jobs at a former spinout and inks new deal with Sobi
April 6, 2021 -
Takeda, CSL to end alliance as plasma-based COVID-19 drug fails key test
April 5, 2021 -
Pfizer vaccine data show durable protection, hint at efficacy against virus variant
April 1, 2021 -
Pfizer, BioNTech's vaccine protects 12- to 15-year-olds from COVID-19 in study
March 31, 2021 -
FDA turns back Keytruda, delaying immunotherapy's arrival in early cancer
March 30, 2021 -
5 FDA approval decisions to watch in the second quarter
March 29, 2021 -
AstraZeneca, under fire, tries to repair image with new vaccine data
March 25, 2021 -
AstraZeneca, Oxford vaccine prevents COVID-19 in big US study amid controversy overseas
March 22, 2021 -
Crunching the numbers on a busy first quarter for biotech IPOs
March 19, 2021 -
EU, UK throw support behind AstraZeneca's vaccine amid reports of rare blood clots
March 18, 2021 -
A first-of-its-kind mRNA drug falls short in cystic fibrosis
March 18, 2021 -
Solid Bio, eyeing comeback, points to 'totality' of new Duchenne gene therapy results
March 16, 2021 -
AstraZeneca says 'no evidence' linking vaccine to clots after multiple countries pause rollout
March 15, 2021 -
FDA sets meeting to review 6 speedy cancer drug approvals as evaluation widens
March 11, 2021 -
Taking a page from Celgene, Takeda builds and buys a cancer biotech
March 9, 2021 -
Crucial data on AstraZeneca's vaccine are coming. Here's what we may learn.
March 8, 2021 -
Lilly drug regrows hair in autoimmune disease study, but safety questions linger
March 3, 2021 -
Merck withdraws Keytruda in type of lung cancer amid 'industry-wide' review by FDA
March 2, 2021 -
A play-by-play of the FDA meeting on J&J's vaccine
Feb. 26, 2021